1. The regulatory effect and mechanism of traditional Chinese medicine on the renal inflammatory signal transduction pathways in diabetic kidney disease: A review
   Xiaoxia Li et al, 2024, Medicine CrossRef
2. Pharmacological potential of Astragali Radix for the treatment of kidney diseases
   Yue Shi et al, 2024, Phytomedicine CrossRef
3. Astragaloside IV Regulates Insulin Resistance and Inflammatory Response of Adipocytes via Modulating CTRP3 and PI3K/AKT Signaling
   Yue Zhang et al, 2022, Diabetes Therapy CrossRef
4. Hedysarum polybotrys polysaccharide attenuates renal inflammatory infiltration and fibrosis in diabetic mice by inhibiting the HMGB1/RAGE/TLR4 pathway
   Changqing Xu et al, 2023, Experimental and Therapeutic Medicine CrossRef
5. Astragaloside IV promotes the pyroptosis of airway smooth muscle cells in childhood asthma by suppressing HMGB1/RAGE axis to inactivate NF-κb pathway
   Huahong Zhang et al, 2024, Autoimmunity CrossRef
6. Advances in oxidative stress in pathogenesis of diabetic kidney disease and efficacy of TCM intervention
   Xiaoju Ma et al, 2023, Renal Failure CrossRef
7. Breviscapine alleviates podocyte injury by inhibiting NF-κB/NLRP3-mediated pyroptosis in diabetic nephropathy
   Linlin Sun et al, 2023, PeerJ CrossRef
8. Astragaloside IV ameliorate acute alcohol-induced liver injury in mice via modulating gut microbiota and regulating NLRP3/caspase-1 signaling pathway
   Shan Wu et al, 2023, Annals of Medicine CrossRef
9. Astragaloside IV Regulates Insulin Resistance and Inflammatory Response of Adipocytes via Modulating MIR-21/PTEN/PI3K/AKT Signaling
   Xuxi Guo et al, 2023, Endocrine, Metabolic & Immune Disorders - Drug Targets CrossRef
10. The efficacy and potential mechanism of Danggui Buxue Decoction in treating diabetic nephropathy: A meta-analysis and network pharmacology
    Yan Zhang et al, 2023, Medicine CrossRef
11. Mechanisms and efficacy of traditional Chinese herb monomers in diabetic kidney disease
    Xuexun Chen et al, 2023, International Urology and Nephrology CrossRef
12. Could Cyclosiversioside F Serve as a Dietary Supplement to Prevent Obesity and Relevant Disorders?
    Siqi Qin et al, 2023, International Journal of Molecular Sciences CrossRef
13. Taurine Ameliorates Apoptosis via AKT Pathway in the Kidney of Diabetic Rats
    Shuangyue Li et al, 2022, Taurine 12 CrossRef
14. Natural products in attenuating renal inflammation via inhibiting the NLRP3 inflammasome in diabetic kidney disease
    Yan Wang et al, 2023, Frontiers in Immunology CrossRef
15. Astragaloside IV inhibits cell viability and glycolysis of hepatocellular carcinoma by regulating KAT2A-mediated succinylation of PGAM1
    Yuanzhang Zhu et al, 2024, BMC Cancer CrossRef
16. Saponin monomers: Potential candidates for the treatment of type 2 diabetes mellitus and its complications
    Lvzhuo Zhang et al, 2024, Phytotherapy Research CrossRef
17. Terpenes in the management of chronic kidney disease
    Piyusha Kulkarni et al, 2024, Naunyn-Schmiedeberg's Archives of Pharmacology CrossRef
18. Chinese herbal medicine and active ingredients for diabetic cardiomyopathy: molecular mechanisms regulating endoplasmic reticulum stress
    Lianjun Ao et al, 2023, Frontiers in Pharmacology CrossRef
19. Saponins as potential novel NLRP3 inflammasome inhibitors for inflammatory disorders
    Jiamei Tang et al, 2024, Archives of Pharmacal Research CrossRef
20. Astragaloside IV Alleviates Renal Tubular Epithelial-Mesenchymal Transition via CX3CL1-RAF/MEK/ERK Signaling Pathway in Diabetic Kidney Disease
    Yonghui Hu et al, 2022, Drug Design, Development and Therapy CrossRef
21. Therapeutic mechanism and clinical application of Chinese herbal medicine against diabetic kidney disease
    Dan-Qian Chen et al, 2022, Frontiers in Pharmacology CrossRef
22. Astragaloside IV Protects against Diabetic Nephropathy by Inhibiting FUNDC1‐Dependent Mitochondria‐Associated Endoplasmic Reticulum Membranes
    Zeng Zhang et al, 2024, Journal of Food Biochemistry CrossRef
23. Radix Astragali and Its Representative Extracts for Diabetic Nephropathy: Efficacy and Molecular Mechanism
    Hui-zhong Xue et al, 2024, Journal of Diabetes Research CrossRef
24. The beneficial effects of astragaloside IV on ameliorating diabetic kidney disease
    Yiwei Gao et al, 2023, Biomedicine & Pharmacotherapy CrossRef
25. Astragaloside-IV promotes autophagy via the Akt/mTOR pathway to improve cellular lipid deposition
    Guo Liu et al, 2024, Medicine CrossRef
26. Investigation of the Metabolism of Astragaloside IV in a Puromycin-Damaged Rat Model by UPLC-Q-TOF-MS/MS Analysis
    Bing Zhang et al, 2024, Planta Medica CrossRef
27. Astragali Radix: comprehensive review of its botany, phytochemistry, pharmacology and clinical application
    Ya-Xiao Liu et al, 2024, Archives of Pharmacal Research CrossRef
28. A natural products solution to diabetic nephropathy therapy
    Qichao Hu et al, 2023, Pharmacology & Therapeutics CrossRef
29. Effects of Zhuang medicine compound Xiancao Granule on diabetic kidney disease: A multi-omics analysis
    Chao Mo et al, 2024, Journal of Ethnopharmacology CrossRef
30. Downregulating lncRNA MIAT attenuates apoptosis of podocytes exposed to high glucose
    Jiayi Xia et al, 2023, Acta Diabetologica CrossRef
31. Renoprotective effect of rosmarinic acid by inhibition of indoxyl sulfate-induced renal interstitial fibrosis via the NLRP3 inflammasome signaling
    Tung-Wei Hung et al, 2024, International Immunopharmacology CrossRef
32. Portrayal of NLRP3 Inflammasome in Atherosclerosis: Current Knowledge and Therapeutic Targets
    Daniela Maria Tanase et al, 2023, International Journal of Molecular Sciences CrossRef
33. The state of astragaloside IV research: A bibliometric and visualized analysis
    Ning Liu et al, 2024, Fundamental & Clinical Pharmacology CrossRef
34. Astragaloside IV protects renal tubular epithelial cells against oxidative stress‐induced injury by upregulating CPT1A‐mediated HSD17B10 lysine succinylation in diabetic kidney disease
    Meng Wang et al, 2024, Phytotherapy Research CrossRef
35. Study on the Mechanism of Radix Astragali in the Treatment of Diabetic Nephropathy Based on Podocyte Injury
    影 邢, 2024, Traditional Chinese Medicine CrossRef
36. A Review of Medicinal Plants with Renoprotective Activity in Diabetic Nephropathy Animal Models
    I Made Wisnu Adhi Putra et al, 2023, Life CrossRef
37. The Potential of Huangqi Decoction for Treating Diabetic Kidney Disease
    Ying Chen et al, 2024, Integrative Medicine in Nephrology and Andrology CrossRef
38. PTP1B Inhibitor Claramine Rescues Diabetes-Induced Spatial Learning and Memory Impairment in Mice
    Mengyu Wu et al, 2023, Molecular Neurobiology CrossRef